Pfizer–BioNTech COVID-19 vaccine

Type of vaccine for humans

Pfizer–BioNTech COVID-19 vaccine    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Pfizer–BioNTech COVID-19 vaccine: Type of vaccine for humans
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in people aged five years and older in some jurisdictions, twelve years and older in some jurisdictions, and for people sixteen years and older in other jurisdictions, to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) encoding a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial advice indicated that vaccination required two doses given 21 days apart, but the interval was later extended to up to 42 days in the US, and up to four months in Canada.


You Might Like

Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the Oxford-AstraZeneca-developed..
IndiaTimes - Published

AstraZeneca and Pfizer safe to use as booster jabs, UK medicines regulator says

astrazeneca and pfizer safe to use as booster jabs, uk medicines regulator says
The UK's medicines regulator has said the Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are safe to use as booster jabs.
Sky News - Published

Covishield becomes collateral damage in inter-EU tussle over Chinese vaccines

EMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria.
DNA - Published

EU hits 100 million COVID vaccine doses - and announces major extension to Pfizer deal

Over 100 million COVID-19 vaccinations have now been given in the EU - and a major extension to the European Commission's contract with Pfizer-BioNTech has been announced.
Sky News - Published
Search this site and the web: